1. Home
  2. CLAR vs ANIX Comparison

CLAR vs ANIX Comparison

Compare CLAR & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$3.06

Market Cap

104.9M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.74

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLAR
ANIX
Founded
1957
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.9M
88.8M
IPO Year
1998
2013

Fundamental Metrics

Financial Performance
Metric
CLAR
ANIX
Price
$3.06
$2.74
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$4.08
$8.67
AVG Volume (30 Days)
279.8K
99.1K
Earning Date
05-07-2026
05-27-2026
Dividend Yield
3.80%
N/A
EPS Growth
11.68
12.82
EPS
N/A
N/A
Revenue
$228,000.00
$210,000.00
Revenue This Year
$5.27
N/A
Revenue Next Year
$3.99
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.53
$2.44
52 Week High
$4.03
$5.46

Technical Indicators

Market Signals
Indicator
CLAR
ANIX
Relative Strength Index (RSI) 57.32 41.38
Support Level $2.59 $2.65
Resistance Level $3.08 $3.12
Average True Range (ATR) 0.15 0.12
MACD 0.03 -0.02
Stochastic Oscillator 86.18 21.48

Price Performance

Historical Comparison
CLAR
ANIX

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: